Georg Vo Beiske, MPharm
Georg Vo Beiske, Mpharm

CEO

Junior Venture Partner at Healthcap and observer to the board of Precirix.

 

Joined Healthcap portfolio company Algeta in 2013, which was acquired by Bayer in 2014 for USD 2.9 Bn.

 

Led a global technical development team at Bayer bringing a targeted thorium conjugate (TTC) from pre-clinical stage into the clinic and led the setup of US manufacturing and supply for the TTC platform.